Any feedback?
Literature summary for 3.4.14.5 extracted from
- Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism? (2008), Naunyn Schmiedebergs Arch. Pharmacol., 377, 205-207.
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| glucagon-like peptide 1 + H2O | Rattus norvegicus | - |
? | - |
? |  |
| peptide YY + H2O | Rattus norvegicus | high affinity substrate of DPP-IV | peptide YY fragment 3-36 | - |
? | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| glucagon-like peptide 1 + H2O | - |
Rattus norvegicus | ? | - |
? | |
| peptide YY + H2O | high affinity substrate of DPP-IV | Rattus norvegicus | peptide YY fragment 3-36 | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| CD26 | - |
Rattus norvegicus |
| dipeptidyl peptidase IV | - |
Rattus norvegicus |
| DPP-IV | - |
Rattus norvegicus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
